2-[1-[[5-(2-aminopyrimidin-5-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]methyl]piperidin-4-yl]propan-2-ol
C23H32N8O2 — CID 140863817
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[1-[[5-(2-aminopyrimidin-5-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]methyl]piperidin-4-yl]propan-2-ol
2-[1-[[5-(2-aminopyrimidin-5-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]methyl]piperidin-4-yl]propan-2-ol (PubChem CID 140863817) has the molecular formula C23H32N8O2 and a molecular weight of 452.56 g/mol. Its IUPAC name is 2-[1-[[5-(2-aminopyrimidin-5-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]methyl]piperidin-4-yl]propan-2-ol.
Molecular Properties
| Compound Name | 2-[1-[[5-(2-aminopyrimidin-5-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]methyl]piperidin-4-yl]propan-2-ol |
|---|---|
| PubChem CID | 140863817 |
| Molecular Formula | C23H32N8O2 |
| Molecular Weight | 452.56 g/mol |
| Exact Mass | 452.26 |
| IUPAC Name | 2-[1-[[5-(2-aminopyrimidin-5-yl)-7-morpholin-4-ylpyrazolo[1,5-a]pyrimidin-2-yl]methyl]piperidin-4-yl]propan-2-ol |
| SMILES | CC(C)(O)C1CCN(Cc2cc3nc(-c4cnc(N)nc4)cc(N4CCOCC4)n3n2)CC1 |
| InChI | InChI=1S/C23H32N8O2/c1-23(2,32)17-3-5-29(6-4-17)15-18-11-20-27-19(16-13-25-22(24)26-14-16)12-21(31(20)28-18)30-7-9-33-10-8-30/h11-14,17,32H,3-10,15H2,1-2H3,(H2,24,25,26) |
| InChIKey | QGNAPMIBAOEPPA-UHFFFAOYSA-N |
| XLogP | 1.59 |
| TPSA | 117.93 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 452.56 |
| LogP ≤ 5 | 1.59 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 140863817 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.